The acquisition should improve the quality of therapy and other mental health outcomes, Sondermind’s CEO said.
Click here to view original post
Related Articles
News
Uniting Communities Through Growing Food: Big Green Announces the Big Green Bus Tour “Grow Together”
March 21, 2024
UCBN
News, Syndication
Comments Off on Uniting Communities Through Growing Food: Big Green Announces the Big Green Bus Tour “Grow Together”
Big Green is driving seeds of change on tour across the nation to fuel a movement that brings communities together over the power of growing food. DENVER, Colo., March 21, 2024 /PRNewswire/ — Big Green, […]
News
Weekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)
October 14, 2022
UCBN
News
Comments Off on Weekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)
The Centers for Medicare & Medicaid Services (CMS) are currently working to develop a new rule that could provide Medicare patients faster access to innovative, lifesaving, and life-enhancing medical devices and diagnostics. This CMS initiative […]
News
Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry
January 26, 2023
UCBN
News
Comments Off on Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry
The Washington-based CDMO AGC Biologics has been tapped to manufacture the type 1 diabetes treatment Tzield from Provention Bio. AGC Biologics will produce Tzield at its Seattle protein biologics site. It was chosen after AGC […]
